Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis pathways in neuroblastoma therapy.

Simone Fulda1, Klaus Michael Debatin

  • 1University Children's Hospital, Prittwitzstr. 43, D-89075 Ulm, Germany.

Cancer Letters
|July 26, 2003
PubMed
Summary

Apoptosis, or programmed cell death, is vital for tissue balance. Understanding how neuroblastoma cells resist apoptosis is key to developing new cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Notice to "Genes Involved in Apoptosis Regulation: Implications for Cancer Therapy".

Current genomics·2025
Same author

Correction to: NF-κB contributes to Smac mimetic-conferred protection from tunicamycin-induced apoptosis.

Apoptosis : an international journal on programmed cell death·2025
Same author

Correction: Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Oncogene·2024
Same author

Editorial Expression of Concern: Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Oncogene·2024
Same author

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.

The Lancet. Oncology·2024
Same author

Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways applying Petri net formalism and in silico knockout analysis.

PLoS computational biology·2022

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Death Research

Background:

  • Apoptosis, the body's programmed cell death process, is essential for maintaining tissue homeostasis.
  • Dysregulation of apoptosis, leading to an imbalance between cell death and proliferation, is a hallmark of tumor formation.
  • Many cancer treatments, including chemotherapy and radiation, induce cancer cell death primarily through apoptosis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying apoptosis induction in cancer therapy.
  • To understand how neuroblastoma cells evade apoptosis, leading to therapeutic resistance.
  • To identify novel therapeutic strategies targeting apoptosis resistance in neuroblastoma.

Main Methods:

  • Review of current literature on apoptosis and cancer therapy.
  • Analysis of molecular pathways involved in apoptosis regulation.
  • Examination of resistance mechanisms in neuroblastoma cells.

Main Results:

  • Impaired apoptosis activation is a significant factor in neuroblastoma's resistance to anticancer treatments.
  • Understanding the molecular basis of apoptosis evasion is crucial for overcoming treatment failure.
  • Insights into apoptosis and alternative cell death pathways can guide the development of new therapeutic approaches.

Conclusions:

  • Targeting apoptosis resistance mechanisms in neuroblastoma offers a promising avenue for improving treatment efficacy.
  • Further research into the molecular intricacies of cell death pathways is essential for advancing neuroblastoma therapy.
  • Novel therapeutic strategies should focus on overcoming neuroblastoma's ability to evade programmed cell death.

Related Experiment Videos